Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood-brain barrier permeability in schizophrenia

American Journal of Psychiatry

Volumn 156, Issue 4, 1999, Pages 634-636

  Müller, Norbert ^a   Riedel, Michael ^a   Hadjamu, Myriam ^a   Schwarz, Markus J ^a   Ackenheil, Manfred ^a   Gruber, Rudolf ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYROPHENONE DERIVATIVE; CELL ADHESION MOLECULE; CLOZAPINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NEUROLEPTIC AGENT; PHENOTHIAZINE DERIVATIVE; THIOXANTHENE DERIVATIVE; VERY LATE ACTIVATION ANTIGEN;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG PENETRATION; FEMALE; HELPER CELL; HUMAN; IMMUNOREGULATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIPSYCHOTIC AGENTS; BLOOD-BRAIN BARRIER; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; FEMALE; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; MALE; PERMEABILITY; RECEPTORS, LYMPHOCYTE HOMING; RECEPTORS, VERY LATE ANTIGEN; SCHIZOPHRENIA; T-LYMPHOCYTES, HELPER-INDUCER; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0342439882     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Schwarz M, Ackenheil M, Riedel M, Müller N: Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia. Neurosci Lett 1998; 253:201-203
2. Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH: Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry 1993; 150:1408-1410
3. De Vries HE, Moor ACE. Blom-Roosemalen MCM, de Broer AG, Breimer DD, van Berkel TJC, Kuiper J: Lymphocyte adhesion to brain capillary endothelial cells in vitro. J Neuroimmunol 1994; 52:1-8
4. Héry C, Sébire G, Peudenier S, Tardieu M: Adhesion to human neurons and astrocytes of monocytes: the role of interaction of CR3 and ICAM-1 and modulation by cytokines. J Neuroimmunol 1995; 57:101-109
5. Oppenheimer-Marks N, Davis LS, Bogue DT, Ramberg J, Lipsky PE: Differential utilisation of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T-lymphocytes. J Immunol 1991; 147:2913-2921
6. 3 uptake. J Neurochem 1994; 62:1112-1118
7. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R, Version 1.0 (SCID). Washington, DC. American Psychiatric Press, 1990
8. Reiber H, Felgenhauer K: Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chem Acta 1987; 163:319-328
9. Müller N, Ackenheil M, Hofschuster E, Mempel W, Eckstein R: Cellular immunity in schizophrenic patients before and during neuroleptic therapy. Psychiatry Res 1991; 37:147-160
10. Burkly LC, Jakubowski A, Newman BM, Rosa MD, Chi-Rosso G, Lobb RR: Signaling by vascular cell adhesion molecule-1 (VCAM-1) through VLA-4 promotes CDS-dependent T cell proliferation. Eur J Immunol 1991; 21:2871-2875